Fonte: British Journal Pharmacology. Nome do evento: Selected Abstracts from Pharmacology 2019. Unidade: ICB
Assuntos: FARMACOLOGIA, DERMATITE EM ANIMAL, LESÕES EM ANIMAIS, ESTRESSE OXIDATIVO, NEOVASCULARIZAÇÃO PATOLÓGICA, PELE DE ANIMAL, DOENÇAS DA PELE E DO TECIDO CONJUNTIVO, CICATRIZAÇÃO, RATOS
ABNT
SÁNCHEZ, Silvia Abigail Coavoy et al. A hydrogen sulfide-releasing dexamethasone derivative attenuates atopic dermatitis severity signs and the associated oxidative stress markers in mice. British Journal Pharmacology. Oxford: John Wiley & Sons Ltd. Disponível em: https://doi.org/10.1111/bph.15035. Acesso em: 01 set. 2024. , 2020APA
Sánchez, S. A. C., Santagada, V., Caliendo, G., Severino, B., & Costa, S. K. P. (2020). A hydrogen sulfide-releasing dexamethasone derivative attenuates atopic dermatitis severity signs and the associated oxidative stress markers in mice. British Journal Pharmacology. Oxford: John Wiley & Sons Ltd. doi:10.1111/bph.15035NLM
Sánchez SAC, Santagada V, Caliendo G, Severino B, Costa SKP. A hydrogen sulfide-releasing dexamethasone derivative attenuates atopic dermatitis severity signs and the associated oxidative stress markers in mice [Internet]. British Journal Pharmacology. 2020 ; 177( 11): 2571-2572.[citado 2024 set. 01 ] Available from: https://doi.org/10.1111/bph.15035Vancouver
Sánchez SAC, Santagada V, Caliendo G, Severino B, Costa SKP. A hydrogen sulfide-releasing dexamethasone derivative attenuates atopic dermatitis severity signs and the associated oxidative stress markers in mice [Internet]. British Journal Pharmacology. 2020 ; 177( 11): 2571-2572.[citado 2024 set. 01 ] Available from: https://doi.org/10.1111/bph.15035